Pfizer
‘More patients want Votrient’
April 2, 2014Research and Development, Sales and Marketing Cancer, GSK, Pfizer, Sutent, Votrient
GlaxoSmithKline is looking at patient satisfaction as a potential marketing tool for its kidney cancer drug Votrient, setting up a …
Pfizer’s Xalkori impresses in new setting
March 26, 2014Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer
Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …
Pfizer sues over Viagra generic
March 18, 2014Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra
Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
NICE U-turn on Pfizer drug Inlyta
March 5, 2014Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta
NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …
Pharma’s reputation ‘getting worse’
February 17, 2014Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation
The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …
Pfizer faces Australia action
February 14, 2014Medical Communications, Sales and Marketing Australia, Lipitor, Pfizer, accc
Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …
INC Research appoints Pfizer head
February 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Pfizer, setnik
Clinical research organisation INC Research has hired Dr Beatrice Setnik from Pfizer to be its vice president of Clinical Pharmacology. …
Drug giants team up for Alzheimer’s
February 5, 2014Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer
The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
Pfizer breast cancer drug shows promise
February 4, 2014Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …
Profits drop for Pfizer
January 29, 2014Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4
Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …
Pfizer lung cancer drug suffers late-stage setback
January 28, 2014Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib
An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …
NHS consults on loosening controls for Viagra
January 23, 2014Sales and Marketing DH, ED, NHS, Pfizer, Sildenafil, viagra
The Department of Health is looking to make cheaper generic versions of Pfizer’s Viagra more widely available to patients with …
Pfizer executive exits leadership team
December 18, 2013Sales and Marketing Pfizer, Read, amy schulman
A leading big pharma figurehead who was to be instrumental in Pfizer’s future plans has stepped down unexpectedly. Amy Schulman …
Pfizer cuts manufacturing again with plant closure
December 9, 2013Manufacturing and Production Ireland, Merck, Pfizer, Taylor, facility
A packaging plant in Ireland is the latest to come into the cross-hairs of the people at Pfizer tasked with …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
